Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1

Research Site 2, Liverpool, New South Wales, Australia

Research Site 3, Auchenflower, Queensland, Australia

Research Site 1, Birtinya, Queensland, Australia

Research Site 4, Melbourne, Victoria, Australia

Research Site 2, Calgary, Alberta, Canada

Research Site 3, Edmonton, Alberta, Canada

Research Site 1, Montreal, Quebec, Canada

Research Site 2, München, Germany

Research Site 1, Ulm, Germany

Research Site 1, Milan, Italy

Research Site 2, Roma, Italy

Research Site 1, Leiden, Netherlands

Research Site 1, Auckland, New Zealand

Research Site 3, Barcelona, Spain

Research Site 2, Madrid, Spain

Research Site 1, Valencia, Spain

Research Site, Bangkok, Thailand